Tandem Diabetes Care (TNDM) Prepaid Assets (2013 - 2026)
Tandem Diabetes Care (TNDM) posted Prepaid Assets of $49.8 million for Q1 2026, up 59.44% on a QoQ basis from $31.2 million in Q4 2025, and up 83.77% year-over-year from $27.1 million in Q1 2025.
Tandem Diabetes Care (TNDM) Prepaid Assets (2013 - 2026) Analysis & Trends
Tandem Diabetes Care's Prepaid Assets history runs 14 years deep, the most recent figure standing at $49.8 million for Q1 2026.
- Quarterly Prepaid Assets rose 83.77% year-over-year to $49.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.8 million (up 83.77% YoY) and the FY2025 annual result came in at $31.2 million, up 42.12% from the prior year.
- Prepaid Assets was $49.8 million for Q1 2026 at Tandem Diabetes Care, up from $31.2 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $49.8 million in Q1 2026 and bottomed at $7.2 million in Q4 2022.
- A 5-year average of $20.3 million and a median of $19.9 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets retreated 14.13% — and 2023, when it surged 129.04%.
- Tandem Diabetes Care's Prepaid Assets stood at $7.2 million in 2022, then jumped by 129.04% to $16.6 million in 2023, then jumped by 32.44% to $22.0 million in 2024, then surged by 42.12% to $31.2 million in 2025, then jumped by 59.44% to $49.8 million in 2026.
- Business Quant data shows TNDM's Prepaid Assets at $49.8 million in Q1 2026, $31.2 million in Q4 2025, and $34.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.77 Mn |
| Dec 31, 2025 | 31.22 Mn |
| Sep 30, 2025 | 34.61 Mn |
| Jun 30, 2025 | 28.44 Mn |
| Mar 31, 2025 | 27.08 Mn |
| Dec 31, 2024 | 21.97 Mn |
| Sep 30, 2024 | 19.89 Mn |
| Jun 30, 2024 | 21.20 Mn |
| Mar 31, 2024 | 20.53 Mn |
| Dec 31, 2023 | 16.59 Mn |
| Sep 30, 2023 | 16.18 Mn |
| Jun 30, 2023 | 10.75 Mn |
| Mar 31, 2023 | 15.38 Mn |
| Dec 31, 2022 | 7.24 Mn |
| Sep 30, 2022 | 8.00 Mn |
| Jun 30, 2022 | 7.85 Mn |
| Mar 31, 2022 | 8.95 Mn |
| Dec 31, 2021 | 8.43 Mn |
| Sep 30, 2021 | 6.76 Mn |
| Jun 30, 2021 | 6.07 Mn |